NCT04143984View on ClinicalTrials.gov

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

December 20, 2025

Study Completion Date

December 20, 2025

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

Induction chemotherapy

Induction chemotherapy with the regimen of gemcitabine plus nedaplatin.

RADIATION

Carbon-ion radiotherapy

Accelerated carbon-ion beam with pencil beam scanning technique.

DRUG

Camrelizumab

An anti-PD-1 antibody.

Trial Locations (1)

201315

RECRUITING

Shanghai Proton and Heavy Ion Center, Shanghai

All Listed Sponsors
lead

Shanghai Proton and Heavy Ion Center

OTHER